OLVIG
CRL icon

Oliver Lagore Vanvalin Investment Group’s Charles River Laboratories CRL Stock Holding History

Oliver Lagore Vanvalin Investment Group’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		$6.02K Buy
+40
New +$5.33K ﹤0.01% 477
2023
Q2 		– Sell
-2
Closed -$404 – 790
2023
Q1 		$404 Buy
+2
New +$453 ﹤0.01% 657

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Oliver Lagore Vanvalin Investment Group's CRL Position: Q2 2025 in Review

Oliver Lagore Vanvalin Investment Group opened a new position in Charles River Laboratories (CRL) in Q2 2025: 40 shares worth $6.02K. The stake represents ﹤0.01% of the portfolio and ranks #477 among its holdings. This is a return to the name: Oliver Lagore Vanvalin Investment Group previously reported a position in CRL as recently as Q1 2023.

Oliver Lagore Vanvalin Investment Group first reported a position in CRL in Q1 2023 and has held it in 2 quarters since. 518 funds tracked by Wall St. Rank hold CRL as of Q2 2025.

  • Oliver Lagore Vanvalin Investment Group held 40 shares of Charles River Laboratories worth $6.02K as of Q2 2025.
  • Charles River Laboratories was a new Oliver Lagore Vanvalin Investment Group position in Q2 2025.
  • Charles River Laboratories made up ﹤0.01% of Oliver Lagore Vanvalin Investment Group's portfolio in Q2 2025, its #477 holding.
  • Oliver Lagore Vanvalin Investment Group first reported a position in Charles River Laboratories in Q1 2023 and has held it in 2 quarters since.
  • 518 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2025.

Based on Oliver Lagore Vanvalin Investment Group's 13F filing for Q2 2025, filed 10 Jul 2025.